Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.32B
sum of reported positions
Reported positions
737
Changes vs prior quarter
737
326 new · 57 exited
Filings on record
8
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q2 2024
Across 192 measured positions in 6 quarters, the typical new or larger position finished −3.0 pts against the S&P 500 and 44% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 214K | $79.8M | 1.5% | |
| 223K | $76.5M | 1.4% | |
| 1.05M | $75.7M | 1.4% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $2.67B | $5.32B |
| Positions | 468 | 737 |
| Biggest line | — | GE Aerospace 2% |
| 324K |
| $72.6M |
| 1.4% |
| 324K | $72.2M | 1.4% |
| 387K | $71.6M | 1.3% |
| 206K | $70.1M | 1.3% |
| 72K | $69.1M | 1.3% |
| 183K | $68.3M | 1.3% |
| 51K | $67.7M | 1.3% |
| 132K | $67.6M | 1.3% |
| 188K | $66.7M | 1.3% |
| 205K | $64.3M | 1.2% |
| 131K | $64.2M | 1.2% |
| 133K | $60.4M | 1.1% |
| 302K | $58.7M | 1.1% |
| 1.3M | $56.3M | 1.1% |
| 219K | $55.8M | 1.1% |
| 1.06M | $52.8M | 1.0% |
| 120K | $51M | 1.0% |
| 288K | $50.8M | 1.0% |
| 187K | $48.6M | 0.9% |
| 385K | $47.1M | 0.9% |
| 1.04M | $46.9M | 0.9% |
| 139K | $45.4M | 0.9% |
Savers Value Village (SVV)
24K shares
Neurocrine Biosciences (NBIX)
1,422 shares
Scholar Rock Holding (SRRK)
4,225 shares
Farmers & Merchants Bancorp (FMAO)
7,515 shares
Investar Holding (ISTR)
7,670 shares
World Kinect Corporation (WKC)
6,938 shares
Karyopharm Therapeutics (KPTI)
23K shares
eXp World Holdings, Inc. (AGNT)
42K shares
RBC Bearings (RBC)
349 shares
Trueblue (TBI)
32K shares
Abacus Global Management (ABX)
21K shares
Powell Industries, Inc. (POWL)
750 shares
Xenon Pharmaceuticals (XENE)
3,405 shares
Tango Therapeutics (TNGX)
6,552 shares
CVB Financial Corp. (CVBF)
8,984 shares
National Beverage Corp. (FIZZ)
6,470 shares
Matador Resources (MTDR)
4,030 shares
Savara (SVRA)
31K shares
Bumble (BMBL)
59K shares
Mannkind (MNKD)
43K shares
Design Therapeutics (DSGN)
13K shares
Corbus Pharmaceuticals Holdings (CRBP)
19K shares
Quanterix (QTRX)
39K shares
Canadian Solar (CSIQ)
10K shares
Grindr (GRND)
11K shares
